# CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations

> **NCT00943488** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 408 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Inactivated H1N1 Vaccine

## Key facts

- **NCT ID:** NCT00943488
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 408 (ACTUAL)
- **Last updated:** 2012-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00943488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00943488, "CSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly Populations". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00943488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*